Bill > HB3064

This bill requires all health benefit plans in Oregon to include comprehensive coverage for perimenopause, menopause, and postmenopause treatments. Specifically, the bill mandates coverage for a wide range of medical interventions, including hormone therapies (such as combination estrogen and hormone medicines), SSRIs and SNRIs (types of antidepressant medications), vaginal estrogen, osteoporosis prevention medications, neurokinin B antagonists, topical hormone therapy, and bioidentical hormones. The coverage is limited to medications approved by the United States Food and Drug Administration. The bill amends existing laws to include these new requirements for health benefit plans offered by the Public Employees' Benefit Board and the Oregon Educators Benefit Board. Additionally, the bill provides for increased expenditure limitations to support these new health insurance benefits, with an increase of $1,109,179 for the Public Employees' Benefit Board and $291,077 for the Oregon Educators Benefit Board. These new requirements will apply to health benefit plans issued, renewed, or extended on or after January 1, 2026, ensuring that women in Oregon have comprehensive health coverage during the perimenopause, menopause, and postmenopause stages of life.